Clinical patterns

Trend & change over time

When the finding is the change rather than the value, two things decide whether the clinician reads it correctly: how the change is scaled, and whether the measurements were ever comparable in the first place. Neither is visible in the number that gets reported.

Stable · v1.0 CarryForward WCAG 2.2 AA IEC 62366-1

Overview

A 7 mm nodule is not a finding. A 7 mm nodule that was 6 mm eighteen months ago might be. The clinical object is the difference, and a difference has properties a value does not: it depends on a baseline someone chose, an interval someone measured, and an assumption that the two ends are commensurable.

This page applies Data visualisation to the case where the change carries the meaning. It does not restate the charting rules — fixed axes, gaps, projections and comparability all live there. What it adds is the thing charts almost universally omit, which is how much change is more than noise.

Change is the finding

The delta, the interval and the rate are stated as clinical facts, not left for the reader to compute from two numbers.

Noise is stated

A change smaller than the measurement's own variability is not a change, and the interface says so rather than drawing it.

Comparable or not compared

Where the ends of a trend were produced differently, the trend is qualified — or it is not offered.

Anatomy

Change, interval, rate and uncertainty together
Right upper lobe nodule · surveillance 4 measurements · 3 years
Current
8.4mm
14 Aug 2026 · scanner B
Change from baseline
+2.4mm
over 3 y 1 mo · from 6.0 mm, 12 Jul 2023
Measurement variability
±1.5mm
inter-reader, this protocol · change exceeds it
Baseline and current were measured on different scanners
Scanner and protocol changed in Jan 2025. Part of the apparent growth may be attributable to the change in method.
PartRule
Current value With unit and provenance, exactly as Key–value pair requires.
Change Signed, with its unit. Never a bare percentage — a 40% increase on a small absolute value is a different clinical object from the same percentage on a large one.
Baseline Named and dated. "Change from baseline" is meaningless without which measurement the baseline is, and baselines get silently reset by data migrations.
Interval The elapsed time, in the units the clinical guidance uses. A delta without an interval cannot be assessed at all.
Variability Required where known. The measurement's own reproducibility, and whether the change exceeds it.
Comparability Any method, protocol, assay or unit change between the compared points, stated adjacent to the change rather than in the chart footnotes.

How much change is a change

The rule that carries the risk

Every measurement has a reproducibility, and most clinical software draws changes far smaller than it as though they were real. A 1.2 mm difference on a measurement with ±1.5 mm inter-reader variability is not growth — it is the same nodule measured twice. Rendering it as a rising line manufactures progression, and progression manufactures scans, biopsies and appointments.

Where the variability is known, the interface states it and says whether the change exceeds it. Where it is not known, that is also stated — an unknown reproducibility is a real limitation and not a reason to imply precision.

A change within the noise, rendered as such
Change from previous
within measurement variability
+0.4 mm over 6 months · variability ±1.5 mm
6.0 mm (Jan) → 6.4 mm (Jul) · same scanner and protocol

The numbers are still there and still checkable. What has changed is the headline: the interface declines to call this growth, because on this measurement it is not distinguishable from none.

Which baseline

"Change from baseline" quietly assumes everyone means the same measurement by baseline. Across three years, four clinicians and a data migration, they do not.

BaselineWhen it is the right one
First recorded Surveillance of a known lesion — the question is total change since discovery.
Immediately previous Interval change — the question is what happened since the last look. Most guidance is written against this one.
Nadir or peak Treatment response, where the comparison is against the best or worst achieved.
Pre-treatment Where an intervention resets what "normal for this patient" means.

Aggregation and what it hides

Long series get aggregated because they have to be. Aggregation is a lossy operation performed on clinical data, and the loss has to be declared.

The window is part of the chart
Nodule long axis · surveillance mm · scale fixed 0–20 · each point one measurement
20 0 no imaging · 14 months 6.0 8.4

Time axis to scale, so the 14-month gap is visibly a gap. Four points, drawn individually — nothing is averaged, and the dashed segment spans both the gap and the scanner change.

States

StateRendering
Single measurement No trend is offered. One point is a value, and drawing a slope from it is the most common way software invents a finding.
Change within variability Stated as such, with both values and the variability figure visible.
Variability unknown Said plainly. The change is shown without a significance claim.
Not comparable The delta is withheld or heavily qualified; the individual values are always shown.
Overdue The trend states when the next measurement was due — a surveillance chart whose latest point is nine months late is mostly telling you that. See Pending work.
Re-analysed Points produced by a different model version are marked, and the original values remain — see Model version change.

Do's and don'ts

Do
Change from previous
within measurement variability
+0.4 mm over 6 months · variability ±1.5 mm

The interface declines to call noise a trend, and shows the numbers that justify declining.

Don't
Growth
+0.4mm
↑ increasing

A difference well inside the measurement's own error, labelled "growth" and given a direction arrow. This is how surveillance escalates for no reason.

Do
Change from baseline
+2.4mm
over 3 y 1 mo · from 6.0 mm, 12 Jul 2023

The baseline is a named, dated measurement. Anyone can check which comparison is being made.

Don't
Change from baseline
+40%

A percentage with no absolute values, no interval, and no indication of which measurement counts as baseline.

Do

Overnight glucose · hourly minimum · 3 excursions below 3.9 mmol/L

Aggregated toward the hazard, with excursions surfaced. The summary answers the question that was actually being asked.

Don't

Overnight glucose · daily mean 7.8 mmol/L

A perfectly reasonable average concealing three hypoglycaemic excursions. The mean of a bad night looks like a good one.

Do

One measurement on file. No trend available. 6.0 mm, 12 Jul 2023.

Refusing to draw a trend from a single point. The value is still shown.

Don't

Stable — no significant change detected.

A reassuring claim derived from one measurement. "Stable" asserts a comparison that has not been made.

Accessibility

Outcomes of use

What this contributes to, in the terms of Usability & context of use. These are attributes believed to contribute to an outcome; the outcome itself is settled by observing real use in a specified context, not by this page.

Clinical safety notes

Risk controls carried by this pattern

Trace these in your risk file (ISO 14971) and usability engineering file (IEC 62366-1).

NotJustAnyMed.Tech Design System · Trend & change over time · v1.0 · draft for review
Reference applications named in this system are fictional; all values, variability figures and surveillance intervals shown are fabricated and illustrative.